Litigation Details for Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH (D. Del. 2023)
✉ Email this page to a colleague
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH (D. Del. 2023)
| Docket | ⤷ Start Trial | Date Filed | 2023-05-19 |
| Court | District Court, D. Delaware | Date Terminated | 2024-03-14 |
| Cause | 35:1 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | BAYER AG | ||
| Patents | 10,828,310; 7,157,456; 9,415,053 | ||
| Attorneys | Andrew L. Brown | ||
| Firms | Morris, Nichols, Arsht & Tunnell | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH
Details for Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH (D. Del. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2023-05-19 | External link to document | |||
| 2023-05-19 | 41 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,415,053 B2. (Attachments:…May 2023 14 March 2024 1:23-cv-00556 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2023-05-19 | 5 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,415,053 B2. (jdb) (Entered:…May 2023 14 March 2024 1:23-cv-00556 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
